News Details
05/05/2025 16:20
Glenmark Pharma - Press Release
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 05, 2025, titled ""Ichnos Glenmark Innovation (IGI) Receives U.S. FDA Fast Track Designation for ISB 2001 for Relapsed/Refractory Multiple Myeloma"".